Skip to content

Use of a Nerve Regeneration Conduit (NerVFIX®) in the Treatment of Nerve Section of the Wrist

Phase II Study Evaluating the Safety and Efficacy of NerVFIX Treatment for Trauma or Accidental Nerve Section of the Wrist

Status
Terminated
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05199155
Enrollment
12
Registered
2022-01-20
Start date
2020-12-08
Completion date
2024-08-13
Last updated
2024-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nerve Injury, Nerve Lesion

Brief summary

The purpose of this open, multicenter trial is to assess the impact of a nerve regeneration conduit made of allogeneic artery or vein from umbilical cord lining on the regeneration of wrist nerve.

Interventions

BIOLOGICALNerVFIX

Decellularized, freeze-dried and sterile allogeneic graft of artery or vein from umbilical cord use by the investigator as a nerve regeneration conduit

Sponsors

TBF Genie Tissulaire
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Men and women over 18 years of age and under 65 years of age * One wrist nerve section ( medial, ulnar) with a minimum of 2 mm and maximum gap of 2 cm evaluated during the surgical procedure (Sunderland Grade V) * Inclusion of direct suture with wrapping or nerve defect with NerVFIX for nerve junction * Poor outcome on the Mackinnon-Dellon scale: \< S3 * Within 1 month of the injury or accident event and/or at the time of the injury (emergency procedure) * Any damaged artery must be repaired * Patient with no poor vascularization risk (no surgical treatment of vessel section) or no disease linked to poor vascularization. * Patient who received the study information and provided consent * Patients who are members or the beneficiary of a national health insurance plan

Exclusion criteria

* Breast feeding women or women without effective contraception (if no effective contraception: a pregnancy test is mandatory) * Digital nerve section * Pregnant or breast feeding women: Women of childbearing age will be asked to undergo a pregnancy test before being enrolled into the study and to use an effective birth control method * Patient who suffered amputation of the hand in question * Surgical site infection or necrotic area; tendon and/or bone damage * Underlying motor or sensory disorder that could compromise the evaluation; inflammatory arthritis causing pain * Disease that compromises healing such as diabetes, alcoholism or skin disorder * Vascular disease leading to reduced blood flow or altered microvascularisation such as Raynaud's disease * Subjects who are unlikely to follow through with rehabilitation or who could be addicted to drugs or alcohol; heavy smokers will be asked to stop smoking voluntarily * Persons confined by a judicial or administrative decision * Adults subject to legal protection measures or who are unable to provide their consent

Design outcomes

Primary

MeasureTime frameDescription
Recovery of sensory function12 monthsRecovery of sensitivity in the nerve section area evaluated using the static 2-Point Discrimination (s2PD)

Secondary

MeasureTime frameDescription
Decrease of the score of symptoms related to nerve section15 days, 1 month, 3 months, 6 months, 12 monthsScore of cold sensitivity, hyperaesthesia and numbing (0 = no complication, 4 = major complication) and score of pain to the pressure (0 = no pain, 10 = worst imaginable pain)
Improvement of the touch-pressure threshold of the hand15 days, 1 month, 3 months, 6 months, 12 monthsTouch-pressure of the hand in grammes determined using Semmes-Weinstein Monofilament (SWM) tests
Progressive recovery of sensory function15 days, 1 month, 3 months, 6 months, 12 monthsImprovement in the s2PD
Improvement of health-related quality of life15 days, 1 month, 3 months, 6 months, 12 monthsQuality of life related to nerve section of the hand evaluated using Quick Disabilities of the Arm, Shoulder and Hand (QuickDASH) questionnaire (0 = no disability, 100 = most severe disability)
Improvement of clinical motricity15 days, 1 month, 3 months, 6 months, 12 monthsImprovement of thumb opposition in case of median nerve section or of Froment's sign, abduction and adduction of the fingers and movement of the 4th and 5th digit in case of ulnar nerve section
Percentage of nerve regeneration1 month, 3 months, 6 months, 12 monthsNerve regeneration after surgical repair evaluated by Hoffman-Tinel sign

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026